How to prevent a feared complication after joint replacement


Treatment gaps

Prior research has shown that women aged 70 years and older are at higher risk for periprosthetic fractures. Many women in this age group who could receive treatment for osteoporosis do not, and major treatment gaps exist worldwide, noted Neil Binkley, MD, with the University of Wisconsin–Madison, in a separate talk at the Santa Fe Bone Symposium.

Ensuring adequate protein intake and addressing the risk of falling are other measures that clinicians can take to promote healthy bones, apart from prescribing drugs, he said.

Unpublished data from one group show that nearly 90% of periprosthetic fractures may result from falls, while about 8% may be spontaneous. “We need to be thinking about falls,” Dr. Binkley said.

Dr. Bukata has consulted for Amgen, Radius, and Solarea Bio and has served on a speakers bureau for Radius. She also is a board member for the Orthopaedic Research Society and the American Academy of Orthopaedic Surgeons Board of Specialty Societies. Dr. Binkley has received research support from Radius and has consulted for Amgen.

A version of this article first appeared on Medscape.com.


Recommended Reading

Delaying denosumab dose boosts risk for vertebral fractures
MDedge Endocrinology
Pandemic hampers reopening of joint replacement gold mine
MDedge Endocrinology
Could an osteoporosis drug reduce need for hip revision surgery?
MDedge Endocrinology
Success in achondroplasia spurs testing vosoritide in more growth disorders
MDedge Endocrinology
We’re dying to tell you about fatigability
MDedge Endocrinology